Mitral regurgitation (MR) is the most common valve disease in the United States. More than 100,000 patients worldwide have been treated with MitraClip™. With low complication rates, a 33% reduction in relative risk of mortality, MitraClip™ cases are growing rapidly and helping patients to significantly improve their quality of life. CMS has recently updated its national coverage determination (NCD) for transcatheter mitral valve repair (TMVr) to include patients with functional/secondary mitral regurgitation (MR).

These represent random sample pages.

Contents include:

  • General Information and FAQs
  • Preparing for your Procedure
  • During Your Procedure
  • Recovering from Your Procedure
  • Care for your Incision Sites
  • Problems to Watch for/ When to call 911
  • Medication Log
  • Details: 8.5 x 11″, 35 pages
    (page count may change depending on your content), full color, custom cover with your hospital logo, custom content and your logo on each page (Available in English and Spanish)
Call 800-408-3464, or email for additional details and pricing.